Armata Pharmaceuticals (ARMP) Operating Income (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.45% |
| Dec 31, 2025 | -77.76% |
| Sep 30, 2025 | -13.62% |
| Jun 30, 2025 | 16.44% |
| Mar 31, 2025 | 22.28% |
| Dec 31, 2024 | -8.03% |
| Sep 30, 2024 | 18.11% |
| Jun 30, 2024 | -16.48% |
| Mar 31, 2024 | -6.78% |
| Dec 31, 2023 | 7.32% |
| Sep 30, 2023 | -7.34% |
| Jun 30, 2023 | 15.13% |
| Mar 31, 2023 | -9.86% |
| Dec 31, 2022 | -19.77% |
| Sep 30, 2022 | 6.48% |
| Jun 30, 2022 | -5.07% |
| Mar 31, 2022 | -45.09% |
| Dec 31, 2021 | 1.55% |
| Sep 30, 2021 | 0.86% |
| Jun 30, 2021 | -14.00% |
| Mar 31, 2021 | 15.78% |
| Dec 31, 2020 | -14.76% |
| Sep 30, 2020 | -22.51% |
| Jun 30, 2020 | 6.73% |
| Mar 31, 2020 | -12.45% |
| Dec 31, 2019 | 35.43% |
| Sep 30, 2019 | -31.39% |
| Jun 30, 2019 | -49.90% |
| Mar 31, 2019 | -23.16% |
| Dec 31, 2018 | -15.03% |
| Sep 30, 2018 | 14.56% |
| Jun 30, 2018 | 6.94% |
| Mar 31, 2018 | -29.18% |
| Dec 31, 2017 | -217.02% |
| Sep 30, 2017 | 92.30% |
| Jun 30, 2017 | -188.36% |
| Mar 31, 2017 | 71.69% |
| Dec 31, 2016 | -248.22% |
| Sep 30, 2016 | 5.07% |
| Jun 30, 2016 | 20.56% |